Roche Agrees to Buy Voting Stake in Novartis for $20.7 Billion
(Novartis) Roche will buy its almost one-third voting right or 53.3 million shares in rival Novartis AG for $20.7 billion. The shares, priced at $388.99 or 356.93 Swiss francs, means…
(Novartis) Roche will buy its almost one-third voting right or 53.3 million shares in rival Novartis AG for $20.7 billion. The shares, priced at $388.99 or 356.93 Swiss francs, means…
Roche has announced a partnership with Moderna to use its Elecsys Anti-SARS-CoV-2 S antibody test in Moderna's mRNA-1273 vaccine trials, according to Roche’s press release. Roche's anti-SARS-CoV-2 antibody test detects…
The U.S. Food and Drug Administration has granted Roche an emergency use authorization (EUA) for Elecsys Anti-SARS-CoV-2 S test, according to Roche’s press release. The test will gauge an individual’s…